toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
  Record Links
Author Russart, K.L.G.; Chbeir, S.A.; Nelson, R.J.; Magalang, U.J. url  doi
  Title Light at night exacerbates metabolic dysfunction in a polygenic mouse model of type 2 diabetes mellitus Type Journal Article
  Year 2019 Publication Life Sciences Abbreviated Journal Life Sci  
  Volume 231 Issue Pages 116574  
  Keywords Animals; diabetes; human health; mouse models; Type 2 diabetes; Insulin Resistance  
  Abstract AIMS: Electric lighting is beneficial to modern society; however, it is becoming apparent that light at night (LAN) is not without biological consequences. Several studies have reported negative effects of LAN on health and behavior in humans and nonhuman animals. Exposure of non-diabetic mice to dim LAN impairs glucose tolerance, whereas a return to dark nights (LD) reverses this impairment. We predicted that exposure to LAN would exacerbate the metabolic abnormalities in TALLYHO/JngJ (TH) mice, a polygenic model of type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: We exposed 7-week old male TH mice to either LD or LAN for 8-10weeks in two separate experiments. After 8weeks of light treatment, we conducted intraperitoneal glucose tolerance testing (ipGTT) followed by intraperitoneal insulin tolerance testing (ipITT). In Experiment 1, all mice were returned to LD for 4weeks, and ipITT was repeated. KEY FINDINGS: The major results of this study are i) LAN exposure for 8weeks exacerbates glucose intolerance and insulin resistance ii) the effects of LAN on insulin resistance are reversed upon return to LD, iii) LAN exposure results in a greater increase in body weight compared to LD exposure, iv) LAN increases the incidence of mice developing overt T2DM, and v) LAN exposure decreases survival of mice with T2DM. SIGNIFICANCE: In conclusion, LAN exacerbated metabolic abnormalities in a polygenic mouse model of T2DM, and these effects were reversed upon return to dark nights. The applicability of these findings to humans with T2DM needs to be determined.  
  Address Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue (up) Edition  
  ISSN 0024-3205 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:31207311 Approved no  
  Call Number GFZ @ kyba @ Serial 2549  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: